Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

被引：41

作者：

Chevalier, Bernard ^{[1
]}

Cequier, Angel ^{[2
]}

Dudek, Dariusz ^{[3
]}

Haude, Michael ^{[4
]}

Carrie, Didier ^{[5
]}

Sabate, Manel ^{[6
]}

Windecker, Stephan ^{[7
]}

Reith, Sebastian ^{[8
]}

Almeida, Manuel de Sousa ^{[9
]}

Campo, Gianluca ^{[10
,11
]}

Iniguez, Andres ^{[12
]}

Onuma, Yoshi ^{[13
]}

Serruys, Patrick W. ^{[14
]}

机构：

[1] Ramsay Gen Sante, Inst Cardiovasc Paris Sud, 6 Ave Noyer Lambert, F-91300 Massy, France

[2] Bellvitge Univ Hosp, Barcelona, Spain

[3] Jagiellonian Univ, Inst Cardiol, Dept Cardiol & Cardiovasc Intervent, Krakow, Poland

[4] Lukaskrankenhaus GmbH, Stadtisches Kliniken Neuss, Neuss, Germany

[5] CHU Rangueil, Dept Cardiol, Toulouse, France

[6] Univ Barcelona, IDIBAPS, Hosp Clin, Cardiovasc Inst, Barcelona, Spain

[7] Bern Univ Hosp, Dept Cardiol, Bern, Switzerland

[8] Univ Hosp RWTH Aachen, Dept Internal Med 1, Aachen, Germany

[9] Ctr Hosp Lisboa Ocidental, Dept Cardiol, Lisbon, Portugal

[10] Azienda Osped Univ Ferrara, Cardiol Unit, Cone, FE, Italy

[11] Maria Cecilia Hosp, GVM Care & Res, Cotignola, RA, Italy

[12] Hosp Alvaro Cunqueiro, Vigo, Spain

[13] Erasmus MC, Thoraxctr, Rotterdam, Netherlands

[14] Imperial Coll London, NHLI, London, England

来源：

EUROINTERVENTION | 2018年 / 13卷 / 13期

关键词：

VASCULAR SCAFFOLD; IMPLANTATION; OUTCOMES; DISEASE; SAFETY;

D O I：

10.4244/EIJ-D-17-00873

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1561 / 1564

页数：4

共 50 条

[1] Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Serruys, Patrick W.
Chevalier, Bernard
Sotomi, Yohei
Cequier, Angel
Carrie, Didier
Piek, Jan J.
Van Boven, Ad J.
Dominici, Marcello
Dudek, Dariusz
McClean, Dougal
Helqvist, Steffen
Haude, Michael
Reith, Sebastian
Almeida, Manuel de Sousa
Campo, Gianluca
Iniguez, Andres
Sabate, Manel
Windecker, Stephan
Onuma, Yoshinobu
LANCET, 2016, 388 (10059): : 2479 - 2491
[2] Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial
Dudek, Dariusz
Onuma, Yoshinobu
Ormiston, John A.
Thuesen, Leif
Miquel-Hebert, Karine
Serruys, Patrick W.
EUROINTERVENTION, 2012, 7 (09) : 1060 - 1061
[3] Four-year results of the AIDA trial: comparison of Absorb bioresorbable scaffold with Xience everolimus-eluting metallic stent in daily clinical practice
Kerkmeijer, L. S. M.
Tijssen, R. Y. G.
Kraak, R. P.
Hofma, S. H.
Arkenbout, E. K.
Van der Schaaf, R. J.
Weevers, A. P. J.
Tijssen, J. G. P.
Piek, J. J.
Henriques, J. P. S.
De Winter, R. J.
Wykrzykowska, J. J.
EUROPEAN HEART JOURNAL, 2020, 41 : 2539 - 2539
[4] Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Dalos, Daniel
Gangl, Clemens
Roth, Christian
Krenn, Lisa
Scherzer, Sabine
Vertesich, Markus
Lang, Irene
Maurer, Gerald
Neunteufl, Thomas
Berger, Rudolf
Delle-Karth, Georg
BMC CARDIOVASCULAR DISORDERS, 2016, 16
[5] Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Daniel Dalos
Clemens Gangl
Christian Roth
Lisa Krenn
Sabine Scherzer
Markus Vertesich
Irene Lang
Gerald Maurer
Thomas Neunteufl
Rudolf Berger
Georg Delle-Karth
BMC Cardiovascular Disorders, 16
[6] Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
Chevalier, Bernard
Onuma, Yoshinobu
van Boven, Ad J.
Piek, Jan J.
Sabate, Manel
Helqvist, Steffen
Baumbach, Andreas
Smits, Pieter C.
Kumar, Ravindra
Wasungu, Luc
Serruys, Patrick W.
EUROINTERVENTION, 2016, 12 (09) : 1102 - 1107
[7] Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial
Onuma, Yoshinobu
Sotomi, Yohei
Shiomi, Hiroki
Ozaki, Yukio
Namiki, Atsuro
Yasuda, Satoshi
Ueno, Takafumi
Ando, Kenji
Furuya, Jungo
Igarashi, Keiichi
Kozuma, Ken
Tanabe, Kengo
Kusano, Hajime
Rapoza, Richard
Popma, Jeffrey J.
Stone, Gregg W.
Simonton, Charles
Serruys, Patrick W.
Kimura, Takeshi
EUROINTERVENTION, 2016, 12 (09) : 1090 - 1101
[8] Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri, Yuki
Onuma, Yoshinobu
Asano, Taku
Iniguez, Andres
Jensen, Lisette Okkels
Cequier, Angel
Hofma, Sjoerd H.
Christiansen, Evald H.
Suttorp, Maarten
Brugaletta, Salvatore
Raeber, Lorenz
Sabate, Manel
Windecker, Stephan
Serruys, Patrick W.
EUROINTERVENTION, 2018, 14 (11) : 1224 - 1226
[9] Reduced radial expansion of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Dalos, D.
Gangl, C.
Roth, C.
Scherzer, S.
Krenn, L.
Vertesich, M.
Lang, I.
Berger, R.
Neunteufl, T.
Delle-Karth, G.
WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S97 - S98
[10] Reduced radial expansion of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
Dalos, D.
Gangl, C.
Roth, C.
Scherzer, S.
Krenn, L.
Vertesich, M.
Lang, I. M.
Berger, R.
Neunteufl, T.
Delle-Karth, G.
EUROPEAN HEART JOURNAL, 2014, 35 : 466 - 467

← 1 2 3 4 5 →